# Glycine to Treat Psychotic Disorders in Children

> **NCT00005658** · PHASE2 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 10 (—)

## Conditions studied

- Psychotic Disorder
- Schizoaffecitve Disorder
- Schizophrenia

## Interventions

- **DRUG:** Glycine

## Key facts

- **NCT ID:** NCT00005658
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** 2002-01
- **Target enrollment:** 10 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005658, "Glycine to Treat Psychotic Disorders in Children". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00005658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*